Evaluation of potential hepatotoxicity, a detailed knowledge of plasma proteins in physiological and pathological states, and identification of biomarkers and effective interventions can all contribute to initial drug development, discovery of molecular markers and drug targets, and early diagnosis and treatment of numerous diseases. To this end, researchers have published three insightful articles in JPA that further our knowledge of drug and endogenous metabolites, pharmacodynamic biomarkers, and potential remedies for treating complex diseases including cancer.

https://www.miragenews.com/advances-in-pharmacometabolomics-proteome-1054317/

#miragenews